# Stereotactic Body Radiotherapy for Head and Neck Tumors

> **NCT01344356** · PHASE4 · COMPLETED · sponsor: **Mercy Research** · enrollment: 19 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck
- Nasopharyngeal Carcinoma
- Salivary Gland Cancer
- Head and Neck Sarcoma
- Paraganglioma of Head and Neck
- Chordoma of Head and Neck
- Chondrosarcoma of Head and Neck
- Angiofibroma of Head and Neck

## Interventions

- **RADIATION:** stereotactic body radiotherapy
- **RADIATION:** Stereotactic body radiotherapy

## Key facts

- **NCT ID:** NCT01344356
- **Lead sponsor:** Mercy Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01344356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01344356, "Stereotactic Body Radiotherapy for Head and Neck Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01344356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*